Literature DB >> 22922352

Brain-derived neurotrophic factor increases the motility of a particular N-methyl-D-aspartate /GABA-responsive subset of neural progenitor cells.

L C Jansson1, L Louhivuori, H-K Wigren, T Nordström, V Louhivuori, M L Castrén, K E Åkerman.   

Abstract

Neurotrophins like brain-derived neurotrophic factor (BDNF) promote the migration of subsets of neural progenitor cells. The mechanism by which motility is increased and the functional properties of BDNF-responsive cells are not very well known. We have used the neurosphere model, combining time-lapse microscopy, immunocytochemistry, and Ca(2+) imaging, to study the effect of BDNF on parameters such as motility and neurotransmitter responsiveness of migrating neural progenitors. At the initiation of differentiation thick glial glutamate-aspartate transporter (GLAST)-positive radial processes emerged from the neurosphere, followed by the exit of neuron-like cells. The neuron-like cells moved outside the radial processes in a phasic manner with intermittent surges of motility and stationary periods. BDNF increased the number and promoted the progress of the neuron-like cells by prolonging surges and decreasing the length of stationary phases. The average rate of cellular movement during surges was unaffected by BDNF. BDNF also caused a several fold increase in positive staining for tropomyosin-related kinase B (TrkB) receptors and neuronal markers such as Calbindin, microtubule-associated protein-2 (MAP-2), and neuron-specific nuclear protein (NeuN) in cells outside the radial network. Calcium imaging allowed for further characterization of the BDNF-responsive cell population. Kainate-responsive cells, denoting the expression of AMPA/kainate receptors, dominated in the outer migration layers while cells responding to (S)-3,5-dihydroxyphenylglycine (DHPG) via metabotropic glutamate receptor 5 (mGluR5) dominated in the inner migration layers. BDNF did not appreciably affect the distribution of these cells but promoted the redistribution of a small subpopulation (about 20%) of N-methyl-D-aspartate (NMDA)- and GABA-responsive cells to the outermost layers of migration. The results demonstrate that BDNF does not affect cell motility per se but alters the phasic behavior of cell movement by promoting periods of high motility in a defined subpopulation of cells which give a robust Ca(2+) response to NMDA and GABA.
Copyright © 2012 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22922352     DOI: 10.1016/j.neuroscience.2012.08.038

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  13 in total

Review 1.  The role of glutamate and its receptors in the proliferation, migration, differentiation and survival of neural progenitor cells.

Authors:  Linda C Jansson; Karl E Åkerman
Journal:  J Neural Transm (Vienna)       Date:  2014-02-23       Impact factor: 3.575

Review 2.  Neurotrophin Signaling and Stem Cells-Implications for Neurodegenerative Diseases and Stem Cell Therapy.

Authors:  Subrata Pramanik; Yanuar Alan Sulistio; Klaus Heese
Journal:  Mol Neurobiol       Date:  2016-11-05       Impact factor: 5.590

3.  Transient receptor potential channels and their role in modulating radial glial-neuronal interaction: a signaling pathway involving mGluR5.

Authors:  Lauri M Louhivuori; Linda Jansson; Pauli M Turunen; Maria H Jäntti; Tommy Nordström; Verna Louhivuori; Karl E Åkerman
Journal:  Stem Cells Dev       Date:  2014-12-17       Impact factor: 3.272

4.  Neurotrophic factors in women with crack cocaine dependence during early abstinence: the role of early life stress.

Authors:  Thiago W Viola; Saulo G Tractenberg; Mateus Luz Levandowski; Júlio Carlos Pezzi; Moisés Evandro Bauer; Antonio Lúcio Teixeira; Rodrigo Grassi-Oliveira
Journal:  J Psychiatry Neurosci       Date:  2014-05       Impact factor: 6.186

Review 5.  Serotonin dysregulation in Fragile X Syndrome: implications for treatment.

Authors:  Alicia C Hanson; Randi J Hagerman
Journal:  Intractable Rare Dis Res       Date:  2014-11

6.  A Randomized, Double-Blind, Placebo-Controlled Trial of Low-Dose Sertraline in Young Children With Fragile X Syndrome.

Authors:  Laura Greiss Hess; Sarah E Fitzpatrick; Danh V Nguyen; Yanjun Chen; Kimberly N Gaul; Andrea Schneider; Kerrie Lemons Chitwood; Marwa Abd Al Azaim Eldeeb; Jonathan Polussa; David Hessl; Susan Rivera; Randi J Hagerman
Journal:  J Dev Behav Pediatr       Date:  2016-10       Impact factor: 2.225

7.  Tissue plasminogen activator contributes to alterations of neuronal migration and activity-dependent responses in fragile X mice.

Authors:  V Swaroop Achuta; Veronika Rezov; Marko Uutela; Verna Louhivuori; Lauri Louhivuori; Maija L Castrén
Journal:  J Neurosci       Date:  2014-01-29       Impact factor: 6.167

8.  BDNF-TrkB axis regulates migration of the lateral line primordium and modulates the maintenance of mechanoreceptor progenitors.

Authors:  Eugene V Gasanov; Lola M Rafieva; Vladimir P Korzh
Journal:  PLoS One       Date:  2015-03-09       Impact factor: 3.240

9.  Prenatal Cocaine Exposure Upregulates BDNF-TrkB Signaling.

Authors:  Andres Stucky; Kalindi P Bakshi; Eitan Friedman; Hoau-Yan Wang
Journal:  PLoS One       Date:  2016-08-05       Impact factor: 3.240

10.  High-Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) Improves Functional Recovery by Enhancing Neurogenesis and Activating BDNF/TrkB Signaling in Ischemic Rats.

Authors:  Jing Luo; Haiqing Zheng; Liying Zhang; Qingjie Zhang; Lili Li; Zhong Pei; Xiquan Hu
Journal:  Int J Mol Sci       Date:  2017-02-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.